Biocryst Pharmaceuticals buy Cantor Fitzgerald
Start price
29.04.25
/
50%
€7.44
Target price
29.04.26
€17.56
Performance (%)
1.64%
End price
30.04.26
€7.56
Summary
This prediction ended on 30.04.26 with a price of €7.56. The BUY prediction by Cantor_Fitzgerald finished with a performance of 1.64%. Cantor_Fitzgerald has a follow-up prediction for Biocryst Pharmaceuticals where he still thinks Biocryst Pharmaceuticals is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biocryst Pharmaceuticals | -6.626% | -6.626% | -24.431% |
| iShares Core DAX® | -0.676% | 4.053% | 2.212% |
| iShares Nasdaq 100 | 0.993% | 10.872% | 38.041% |
| iShares Nikkei 225® | 3.279% | 13.468% | 59.003% |
| iShares S&P 500 | 0.621% | 6.195% | 26.154% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $20.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat
In the thread Trading Biocryst Pharmaceuticals
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Current prediction by Cantor_Fitzgerald for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€5.72
15.10.25
15.10.25
€22.38
15.10.26
15.10.26
28.64%
13:28
13:28
